Biologic refractory disease in rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis

OBJECTIVES: Biologic disease-modifying antirheumatic drugs (bDMARDs) have revolutionised treatment and outcomes for rheumatoid arthritis (RA). The expanding repertoire allows the option of switching bDMARD if current treatment is not effective. For some patients, even after switching, disease contro...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ann Rheum Dis
Autors principals: Kearsley-Fleet, Lianne, Davies, Rebecca, De Cock, Diederik, Watson, Kath D, Lunt, Mark, Buch, Maya H, Isaacs, John D, Hyrich, Kimme L
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2018
Matèries:
Clinical and Epidemiological Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6161665/
https://ncbi.nlm.nih.gov/pubmed/29980575
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/annrheumdis-2018-213378
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars